The People Behind
the Purity

Dr. Alara Novak, Ph.D.

Chief Research Officer

Dr. Novak leads Nexphoria's compound sourcing, quality standards, and research documentation. Her background in peptide pharmacology and receptor biology shapes every quality decision we make. Prior to founding Nexphoria, she spent a decade evaluating GMP synthesis partners for academic and commercial research use — an experience that became the foundation for our vendor qualification process.

Marcus Reinholt, M.S.

Director of Quality Assurance

Marcus built our multi-lab testing protocol from scratch. He established the specification sheets, rejection criteria, and analytical review workflows that every Nexphoria batch goes through before it reaches a researcher's hands. His rule: no COA gets approved unless the HPLC trace, mass spec confirmation, and endotoxin result all come back independently — never as a package from a single testing facility.

Dr. Sophie Andreasen, Pharm.D.

Research Support Lead

Dr. Andreasen works directly with research teams to translate compound specifications into practical protocols. She developed Nexphoria's reconstitution guides, storage documentation, and the compound stability database that powers our Peptide Stability Checker tool. She answers the hard questions: which solvent for this peptide, how long will it hold at −20°C, what does this HPLC peak mean.

David Klemm

Supply Chain & Cold-Chain Director

David manages every step of how compounds move from synthesis to your lab. He built the temperature-monitoring protocols for transit-sensitive SKUs, established our insulated packaging standards, and negotiated the carrier agreements that guarantee next-day cold-pack performance. His mandate is simple: when the vial arrives, it should be exactly as it left the facility — thermally and chemically.

Dr. Yuna Sato, Ph.D.

Synthesis Partner Relations & Compliance Officer

Dr. Sato is responsible for qualifying, auditing, and maintaining relationships with Nexphoria's synthesis partners. She reviews SPPS protocols, cleavage and deprotection records, and purification run data before any partner is approved to supply us. Her team performs site visits and unannounced audits. She also oversees RUO classification compliance and handles all regulatory correspondence.